ClinicalTrials.govpublic full text
Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection
severe acute respiratory syndrome coronavirus 2, ruxolitinib, acute respiratory distress syndrome, covid-19, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888670
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.